Metropolis Healthcare Share Price
Metropolis Healthcare Share Price Today
As of 6 Jul 2026, Metropolis Healthcare share price is ₹555.95. The stock opened at ₹544.95, compared to its previous close of ₹544.30. During today's trading session, Metropolis Healthcare share price moved in the range of ₹544.30 to ₹559.10, with an average price of ₹551.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹412.25 and a high of ₹600.00. On the performance front, Metropolis Healthcare share price has increased by 15.04% over the last six months and is up 27.97% on a year-on-year basis.
Metropolis Healthcare Returns Calculator
Metropolis Healthcare Shareholder Returns
Metropolis Healthcare Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
Metropolis Healthcare Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,331.20 | ₹1,207.71 | ₹1,148.21 | ₹1,228.34 |
| Other Income | ₹15.11 | ₹9.12 | ₹15.22 | ₹17.62 |
| Total Revenue | ₹1,346.32 | ₹1,216.83 | ₹1,163.43 | ₹1,245.96 |
| Total Expenses | ₹1,155.46 | ₹1,042.14 | ₹975.93 | ₹968.51 |
| Profit Before Tax | ₹190.85 | ₹174.69 | ₹187.50 | ₹293.35 |
| Tax | ₹45.34 | ₹46.23 | ₹44.11 | ₹78.67 |
| Profit After Tax | ₹145.51 | ₹128.46 | ₹143.39 | ₹214.69 |
| EPS - Basic | ₹28.29 | ₹24.95 | ₹27.91 | ₹41.87 |
| EPS - Diluted | ₹28.15 | ₹24.87 | ₹27.81 | ₹41.66 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹190.85 | ₹174.69 | ₹187.50 | ₹293.35 |
| Income before WC changes | ₹322.43 | ₹296.00 | ₹291.56 | ₹352.18 |
| Change in Assets | -₹16.20 | -₹8.02 | ₹19.44 | -₹11.23 |
| Change in Liabilities | ₹0.49 | ₹13.47 | -₹12.33 | -₹5.16 |
| Change in WC | -₹15.71 | ₹5.45 | ₹7.11 | -₹16.40 |
| Cash flow from Operations | ₹262.75 | ₹264.07 | ₹247.09 | ₹253.27 |
| Cash flow from Investing | -₹201.06 | -₹89.41 | ₹46.79 | -₹737.57 |
| Cash flow from Financing | -₹86.63 | -₹181.20 | -₹292.33 | ₹162.52 |
| Total Cash Flow | -₹24.94 | -₹6.54 | ₹1.56 | -₹321.78 |
| Cash (Start of the year) | ₹62.62 | ₹68.83 | ₹65.98 | ₹386.59 |
| Cash (End of the year) | ₹39.48 | ₹62.62 | ₹68.83 | ₹65.98 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,521.24 | ₹1,239.23 | ₹1,198.87 | ₹1,137.17 |
| Current Assets | ₹345.94 | ₹315.83 | ₹302.73 | ₹393.12 |
| Total Assets | ₹1,867.18 | ₹1,555.06 | ₹1,501.61 | ₹1,530.29 |
| Current Liabilities | ₹294.33 | ₹245.87 | ₹264.97 | ₹301.55 |
| Net Current Asset | ₹51.61 | ₹69.96 | ₹37.76 | ₹91.57 |
| Non-Current Liabilities | ₹238.20 | ₹209.91 | ₹245.93 | ₹340.58 |
| Equity Capital | ₹1,334.64 | ₹1,099.27 | ₹990.71 | ₹888.17 |
| Total Equity & Liabilities | ₹1,867.18 | ₹1,555.06 | ₹1,501.61 | ₹1,530.29 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,216.54 | ₹1,103.43 | ₹1,066.04 | ₹1,157.01 |
| Other Income | ₹17.05 | ₹12.00 | ₹21.28 | ₹16.15 |
| Total Revenue | ₹1,233.59 | ₹1,115.42 | ₹1,087.32 | ₹1,173.16 |
| Total Expenses | ₹1,071.57 | ₹958.01 | ₹908.38 | ₹917.51 |
| Profit Before Tax | ₹162.02 | ₹157.41 | ₹178.95 | ₹271.55 |
| Tax | ₹37.23 | ₹41.52 | ₹40.00 | ₹72.01 |
| Profit After Tax | ₹124.80 | ₹115.89 | ₹138.95 | ₹199.53 |
| EPS - Basic | ₹24.35 | ₹22.63 | ₹27.14 | ₹39.00 |
| EPS - Diluted | ₹24.24 | ₹22.55 | ₹27.05 | ₹38.81 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹162.02 | ₹157.41 | ₹178.95 | ₹271.55 |
| Income before WC changes | ₹288.40 | ₹273.92 | ₹275.06 | ₹325.88 |
| Change in Assets | ₹11.89 | ₹8.25 | ₹21.82 | -₹3.27 |
| Change in Liabilities | ₹8.51 | ₹14.09 | -₹15.12 | -₹2.40 |
| Change in WC | ₹20.39 | ₹22.34 | ₹6.70 | -₹5.67 |
| Cash flow from Operations | ₹275.01 | ₹269.01 | ₹237.74 | ₹244.04 |
| Cash flow from Investing | -₹196.09 | -₹81.00 | ₹46.72 | -₹738.21 |
| Cash flow from Financing | -₹84.50 | -₹183.00 | -₹287.87 | ₹171.97 |
| Total Cash Flow | -₹5.58 | ₹5.01 | -₹3.40 | -₹322.20 |
| Cash (Start of the year) | ₹28.59 | ₹24.09 | ₹27.49 | ₹347.68 |
| Cash (End of the year) | ₹22.68 | ₹28.59 | ₹24.09 | ₹27.49 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,428.78 | ₹1,200.26 | ₹1,168.86 | ₹1,105.36 |
| Current Assets | ₹256.12 | ₹272.44 | ₹265.44 | ₹353.18 |
| Total Assets | ₹1,684.90 | ₹1,472.70 | ₹1,434.29 | ₹1,458.54 |
| Current Liabilities | ₹245.08 | ₹234.37 | ₹253.27 | ₹286.92 |
| Net Current Asset | ₹11.04 | ₹38.07 | ₹12.17 | ₹66.26 |
| Non-Current Liabilities | ₹195.38 | ₹207.14 | ₹245.01 | ₹332.42 |
| Equity Capital | ₹1,244.45 | ₹1,031.19 | ₹936.02 | ₹839.21 |
| Total Equity & Liabilities | ₹1,684.90 | ₹1,472.70 | ₹1,434.29 | ₹1,458.54 |
About Metropolis Healthcare
Engaged in diagnostic services, Metropolis Healthcare Limited offers a range of clinical laboratory tests and profiles used for early detection, confirmation and monitoring of disease. It also offers analytical and support services to clinical research organisations for their clinical research projects. The company’s services include pathology testing services, corporate wellness, clinical research services and labs in hospitals. Metropolis Healthcare owns diagnostic centres in the Middle East, South Asia and Africa along with its network in India spread across more than 220 cities.
Metropolis has invested in a variety of specialised tests and several advanced tests and technologies introduced in the global market. The company has nearly 2800 specialised tests.
Business operations
Metropolis Healthcare was started in 1980 as a single diagnostic laboratory in Mumbai by Dr Sushil Kanubhai Shah. The company became a public entity in 2006 and was renamed Metropolis Health Services (India) Limited. The company established its first referral laboratory in 1981. Metropolis started clinical research services in 1992. Ameera Sushil Shah joined the team of Metropolis as one of the partners in the company in 1998. She played a major role in the company's growth strategy and was key to its expansion. In 2001, the company completed its first major acquisition and took over the business of Sudharma, Kerala, in 2001. The same year the company introduced its home service vertical.
In 2006, Metropolis received capital funding from ICICI Ventures. The company executed a secondary transaction by Foxcreek Investment Limited, an affiliate company of Warburg Pincus. The company sets its foot outside the Indian market, taking its services to developing African countries. In 2015, Warburg Pincus exited the company, giving the promoters management control of the firm.
The company inducted a new professional team and rolled out the Metropolis retail strategy in 2016.
In 2019-20, was a year of growth for the company as it pushed for retail expansion. Metropolis also initiated its first public-private partnership (PPP). The company launched its initial public offering (IPO) and was listed on the Indian stock markets.
In 2021-22, the company acquired Hitech Diagnostics Centre to boost its presence in the South Indian markets. It also initiated a network expansion project (90:30) with 90 labs and 1,800 service collection centres in tier 2 and tier 3 cities across India. Metropolis absorbed 8 wholly-owned subsidiaries into the company.
It also became the industry’s first firm to introduce an Employee Value Proposition (EVO). The company rolled out the Metropolis 3.0 strategy to expand its consumer reach via a direct-to-consumer model.
As of January 10, 2024, the company’s market capitalisation is valued at over ₹ 8,200 crores. Metropolis Healthcare’s share price has slipped by over 23% in the last three years.
Metropolis Healthcare Financial Highlights
- Revenue: Metropolis Healthcare reported revenue of ₹1,671.43 crore in FY26 vs ₹1,346.31 crore in FY25. It showed an increase of 24.15% on a yearly basis.
- Operating Profit: Metropolis Healthcare reported an operating profit of ₹259.18 crore in FY26 vs ₹190.85 crore in FY25. It showed an increase of 35.80% on a year-on-year basis.
- Net Profit: Metropolis Healthcare reported a net profit of ₹191.18 crore in FY26 vs ₹145.51 crore in FY25. It showed an increase of 31.39% on a yearly basis.
Metropolis Healthcare Quarterly Result Highlights
- Metropolis Healthcare reported revenue of ₹432.84 crore in Mar 2026, compared with ₹414.93 crore in Dec 2025, representing an increase of 4.32% on a quarter-on-quarter (QoQ) basis.
- Metropolis Healthcare reported an operating profit of ₹69.76 crore in Mar 2026, compared with ₹57.16 crore in Dec 2025, representing an increase of 22.04% on a quarter-on-quarter (QoQ) basis.
- Metropolis Healthcare reported a profit of ₹50.96 crore in Mar 2026, compared with ₹42.09 crore in Dec 2025, reflecting an increase of 21.07% on a QoQ basis.
- The earnings per share (EPS) of Metropolis Healthcare stood at ₹28.29 during Mar 2026.
Similar Stocks
FAQs on Metropolis Healthcare Share Price
What is Metropolis Healthcare share price today?
Metropolis Healthcare share price is ₹555.95 as on 03 Jul, 2026, 15:29 IST.
How has the Metropolis Healthcare share price performed in the past?
In the last 1 year, Metropolis Healthcare delivered a return of 27.97%. The Metropolis Healthcare share price hit a high of ₹600.00 and low of ₹412.25.
How much is the Mutual Fund shareholding in Metropolis Healthcare shares?
The Mutual Fund Shareholding in Metropolis Healthcare was 33.28% at the end of Mar 2026.
What is the the 52-week high and low of Metropolis Healthcare shares ?
The 52-week high and low of Metropolis Healthcare share is ₹600.00 and ₹412.25 as of 03 Jul, 2026.
What is the market cap of Metropolis Healthcare?
The market capitalisation of Metropolis Healthcare is ₹11,274.70 Crores as on 03 Jul, 2026.
What are the stock symbols of Metropolis Healthcare?
The stock symbol of Metropolis Healthcare is METROPOLIS on the NSE, 542650 on the BSE, and the ISIN is INE112L01020.
What was yesterday's closing price of Metropolis Healthcare shares ?
Metropolis Healthcare shares closed yesterday at ₹544.30 on NSE & ₹543.80 on BSE
How to buy Metropolis Healthcare shares?
To buy Metropolis Healthcare shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Metropolis Healthcare shares on Holidays?
No, shares of Metropolis Healthcare or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Metropolis Healthcare shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Metropolis Healthcare?
The PE and PB ratio of Metropolis Healthcare is 58.98 and 7.45 respectively, as on 03 Jul, 2026, 15:29 IST.